Risk and timing of isotretinoin-related laboratory disturbances: a population-based study.
Shirin EmtenaniMariam AbdelghaffarRalf J LudwigEnno SchmidtKhalaf KridinPublished in: International journal of dermatology (2024)
Isotretinoin is associated with a clinically marginal increased risk of severe hypertriglyceridemia and hypertransaminasemia. Routine blood testing should be performed 1-3 months after commencing therapy.